Diagnosis and treatment of neurally mediated syncope

Neurologist

Volumn 8, Issue 3, 2002, Pages 175-185

  Kaufmann, Horacio ^a   Bhattacharya, Kirsty ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelin; Neurally mediated syncope; Nitric oxide; Norepinephrine; Pacemakers; Pharmacologic treatment; Tilt table test; Vasopressin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DISOPYRAMIDE; ENDOTHELIN; FLUDROCORTISONE; GLYCERYL TRINITRATE; ISOPRENALINE; MIDODRINE; MINERALOCORTICOID; NEUROLEPTIC AGENT; NITRATE; NITRIC OXIDE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; VASOPRESSIN;

AMBULATORY MONITORING; ARTIFICIAL HEART PACEMAKER; AUTONOMIC NERVOUS SYSTEM; BLADDER NECK STENOSIS; BLOOD PRESSURE MONITORING; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN STEM; CARDIOVASCULAR AUTOREGULATION; CHEMORECEPTOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; EMOTION; HEAD TILTING; HEART RATE; HUMAN; HYPERTENSION; MECHANORECEPTOR; MICROGRAVITY; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULAR FORMATION; REVIEW; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SINGLE BLIND PROCEDURE; SYNCOPE; TREADMILL EXERCISE; VASODILATATION;

EID: 0036273678     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-200205000-00004     Document Type: Review

References (65)

1. Epidemiologic features of isolated syncope: The Framingham Study
2. Patients with syncope admitted to medical intensive care units
3. Syncope. A neurologist's viewpoint
4. The Bezold-Jarisch reflex revisited: Clinical implications of inhibitory reflexes originating in the heart
5. Ventricular syncope: Is the heart a sensory organ?
6. Vasovagal reactions may occur after orthotopic heart transplantation
7. Orthostatic intolerance after spaceflight
8. Work capacity during 30 days of bed rest with isotonic and isokinetic exercise training
9. Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight
10. Baroreflex dysfunction induced by microgravity: Potential relevance to postflight orthostatic intolerance
11. Head-down bed rest impairs vagal baroreflex responses and provokes orthostatic hypotension
12. Sympathetic outflow to muscles during vasovagal syncope
13. Plasma endothelin during upright tilt: Relevance for orthostatic hypotension?
14. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure
15. The contribution made by adrenaline to the vasodilation in the human forearm during emotional stress
16. Possible increase in the synthesis of endothelial derived relaxing factor (EDRF) during vasovagal syncope
17. Middle cerebral artery velocity during head-up tilt induced hypovolemic shock in humans
18. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance
19. Complex demodulation of cardiorespiratory dynamics preceding vasovagal syncope
20. The lungs as receptor sites for cardiovascular regulation
21. A prospective evaluation and follow-up of patients with syncope
22. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography
23. Exercise stress testing for exposure of cardiac arrhythmia
24. Syncope: The diagnostic value of head-up tilt testing
25. The neuropathic postural tachycardia syndrome
26. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency
27. Head-up tilt: A useful test for investigating unexplained syncope
28. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin
29. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
30. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope
31. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
32. Methodology of isoproterenol-tilt table testing in patients with syncope
33. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol
34. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing
35. Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing
36. Adenosine: Potential modulator for vasovagal syncope
37. Adenosine-induced atrioventricular block in patients with unexplained syncope: The diagnostic value of ATP testing
38. Can adenosine 5-triphosphate be used to select treatment in severe vasovagal syndrome
39. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram
40. Signal averaging of the surface QRS complex predicts inducibility of ventricular tachycardia in patients with syncope of unknown origin: A prospective study
41. The value of electrophysiologic studies in syncope of undetermined origin: Report of 150 cases
42. Role of cardiac electrophysiologic studies in patients with unexplained recurrent syncope
43. Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome
44. Electrophysiologic evaluation and outcome of patients with syncope of unknown origin
45. Electrophysiologic evaluation of elderly patients with sinus bradycardia: A long-term follow-up study
46. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope
47. Fludrocortisone versus beta-adrenergic blockers in the treatment of vasovagal syncope
48. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents
49. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
50. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study
51. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)
52. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine
53. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
54. Midodrine: A role in the management of neurocardiogenic syncope
55. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt
56. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
57. Head up tilt, lower body negative pressure, pacemakers and vasovagal syncope
58. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary. A report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
59. Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group
60. Lecture on vasovagal syncope and the carotid sinus mechanism
61. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
62. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
63. Cardiac pacing for prevention of recurrent vasovagal syncope
64. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope
65. Prolonged asystole during head-up tilt table testing after beta blockade